Vanderbilt-Ingham Cancer Center

Nashville, Tennessee 37232

We've found

1 trials

at this facility

Study of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ HER2- Advanced Breast Cancer

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Nashville, TN

Use our guide to learn which trials are right for you!